-
Interview with Scott Applebaum, President of Context Therapeutics - Part II
Post on 7/10/18
-
Interview with Scott Applebaum, President of Context Therapeutics - Part I
Post on 6/29/18
-
Verrica Pharmaceuticals Closes IPO
Post on 6/19/18
-
New Study Finds Reusable Bronchoscopes Contaminated and Damaged Even When Proper Cleaning and Disinfection Steps are Taken
Post on 6/18/18
-
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
Post on 6/17/18
-
Verrica Pharmaceuticals Goes Public
Post on 6/14/18
-
HC2 Sells BeneVir Biopharm To Janssen Biotech For $1.04 Billion
Post on 6/11/18
-
PANTHERx Specialty Pharmacy Selected by Ultragenyx to Distribute Crysvita
Post on 6/7/18
-
Noble Life Sciences Selects Comprehensive Suite of Preclinical Software Solutions from Instem
Post on 6/6/18
-
Madrigal Pharmaceuticals Proposes Public Offering of Common Stock
Post on 6/5/18
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 6/4/18
-
Optinose Announces Launch of Public Offering of Common Stock
Post on 6/4/18
-
VWR Named Sole Supplier for Cell and Gene Therapy Catapult
Post on 5/24/18
-
Recro Pharma Receives Complete Response Letter from the FDA
Post on 5/24/18
-
Fibrocell Announces One-for-Five Reverse Stock Split
Post on 5/24/18
-
Boston Medical Center Wins ECRI Institute's Award for Pulmonary Care App
Post on 5/17/18
-
PANTHERx Specialty Pharmacy Wins Patient Choice Award
Post on 5/8/18
-
Trevena Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 5/8/18
-
Strongbridge Biopharma plc Announces New Employment Inducement Awards
Post on 5/3/18
-
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 5/2/18
-
Marinus Pharmaceuticals Provides Business Update
Post on 5/2/18
-
Onconova Therapeutics Closes $28.75M Offering
Post on 5/1/18
-
Trevena and Jiangsu Nhwa Pharmaceutical Co. Ltd Announce License Agreement for Oliceridine in China
Post on 5/1/18
-
Onconova Therapeutics Prices $25.0M Upsized Underwritten Public Offering
Post on 4/27/18
-
Palmyra Nursing Homes Awarded Five-Stars by Centers for Medicare and Medicaid
Post on 4/26/18
